Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.

MLA

Edwards, Nicola C., et al. “Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease: A Randomized Controlled Trial.” Journal of the American College of Cardiology, vol. 54, no. 6, Aug. 2009, pp. 505–12. EBSCOhost, https://doi.org/10.1016/j.jacc.2009.03.066.

APA

Edwards, N. C., Steeds, R. P., Stewart, P. M., Ferro, C. J., & Townend, J. N. (2009). Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. Journal of the American College of Cardiology, 54(6), 505–512. https://doi.org/10.1016/j.jacc.2009.03.066

Chicago

Edwards, Nicola C, Richard P Steeds, Paul M Stewart, Charles J Ferro, and Jonathan N Townend. 2009. “Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease: A Randomized Controlled Trial.” Journal of the American College of Cardiology 54 (6): 505–12. doi:10.1016/j.jacc.2009.03.066.